Congratulations to the EverCare team on securing an additional 1.5MDKK from Innovationsfonden Denmark. The R&D team have made tremendous progress transitioning from concept to prototype over the course of the last 12 months. The grant/extension will support technical refinement of the the concept and the crucial work of customer/commercial validation.
Diagnostic innovation is by far one of the most challenging spaces in which to develop novel commercial concepts. To ease and structure the complex process, a European Consortium has been working on the development of a support framework to guide would-be founders on the technical, regulatory and commercial development of diagnostic/biomarker focused companies.
The framework can be found via:
The EverCare team has raised 1.5 MDKK to support the de-risking of a commercial concept based on a technology platform with broad potential. The budget will support Research and Development work to translate the concept into a minimum viable product.
The TresActio team has been accepted to the Novo Nordisk Bioinnovation Institutes Business Accelerator program. Focusing on commercial development of IP generated at Siemens, the team has now raised close to 1MDKK. Congratulations to the entire team on acceptance to the highly competitive program.